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Abstracts / International Journal of Surgery 8 (2010) 501–578 575knee OA and ACL macroscopic and histological status is unclear. This study
aimed todetermine the incidenceofpriorACLdeﬁciencyor injury inpatients
undergoing total knee replacement (TKR), the incidence of ACL rupture at
TKR and to examine the ACL histologically for degenerative change.
Methods: 95 patients undergoing elective TKR for OA were recruited. Pre-
operative knee function was assessed via patient history and standardised
questionnaire, and standardised ligament examination, including measure-
ment of laxity using the KT1000 arthrometer. The ACL was examined
macroscopically at TKR and 10 ACL specimens were examined histologically.
Results: The ACL was absent in 12% of the patients. No signiﬁcant corre-
lation was found between the examination ﬁndings, pre-operative func-
tion and ACL surgical status. The ACL samples all demonstrated
degenerative change of varying severities.
Conclusions: ACL rupture is uncommon inpatients undergoing TKR for OA,
as is previous index injury. The histological ﬁndings suggest that degener-
ation of the ligament occurs in OA, but not that this leads to rupture. In
patients with advanced OA, ACL absence does not worsen function.LATERAL EPICONDYLITIS OF THE ELBOW-ARE PLATELETS THE
ANSWER?
R. Kakkar, M.M. Scott. Northumbria Healthcare NHS Trust
Elbow epicondylar tendinosis is a common problem that usually resolves
with nonoperative treatments. Platelets release many bioactive proteins
responsible for removal of necrotic tissue and enhance tissue regeneration
and healing.Based on this principle platelets are introduced to stimulate
a supra-physiologic release of growth factors in an attempt to jump start
healing in chronic conditions like lateral epicondylitis. 30 patients met the
study criteria and were surgical candidates who had failed conservative
treatments. Allwere treatedwith one Platelet Rich Plasma(GPS III) injection
and their scores evaluated pre and post injection by a Quick DASH score.
The average preinjection quick DASH score was 80. 18 patients(60%) noted
improvement according to Quick DASH scores(13.50) at 8 weeks, 21
patients(70%) at 6 months, and 20(68)% at ﬁnal follow-up at 12months.
These results were statistically signiﬁcant(p< 0.05) for an improvement in
outcome. These results compare favorably with other treatments including
surgery for lateral epicondylitis. We believe that Platelet rich Plasma(PRP)
injection certainly is a useful addition to the orthopaedic surgeons’ arma-
mentarium. Even if it does not permanently cure lateral epicondylitis it can
certainly provide the patient with quality time for the time its effect lasts.EMERGENT THORACOTOMY FOR BLUNT TRAUMA-IS THE OUTCOME
SO BAD?
T.C. Konig, R. Davenport, W. Sapsford, M.S. Walsh, K. Brohi, N.R.M. Tai.
Introduction: Survival after blunt trauma thoracotomy is rare and blunt
mechanism is often considered a contraindication. We reviewd all blunt
trauma patients who underwent a thoracotomy at our institution since
2004.
Results: Since 2004, 33 patients underwent resuscitative thoracotomy
following blunt trauma. 21 patients were male and the median agewas 39.
Pedestrians in road trafﬁc collisions and falls from height accounted for
over half the patients. 6 patients (18%) survived to neurologically intact
hospital discharge. In the survivor group the median initial GCS was 15
(interquartile range 14,15), the systolic blood pressure (SBP)was 102mmHg
(76,122) and the median ISS was 32 (21, 38). Of the survivors 3 underwent
myocardial repair and 3 required lung repair. In the non survivor group the
median presenting GCSwas 8 (3,14), the SBPwas 85mmHg (65, 99) and themedian ISS was 38 (29, 43). Therewas no signiﬁcant difference in themean
ISS for the two groups. In the non survivor group the chest was the most
severely injured body region in 22 patients.
Conclusions: The survival rate of 18% is below the survival rate for
penetrating trauma in this institution but compares favorably with other
published blunt survival rates.IS OTITIS MEDIA WITH EFFUSION (OME) CAUSED BY BACTERIA IN
A BIOFILM? ELUCIDATING THE PATHOGENESIS OF OME.
S. Imtiaz-Umer 1, R. Bayston 2, J.P. Birchall 3, N. Fergie 3. 1Medical Student,
Graduate Entry Medicine, University of Nottingham; 2 Biomaterials-
Related Infection Group, University of Nottingham; 3Department of
Otorhinolaryngology Head & Neck Surgery, University of Nottingham
Otitis media with effusion (OME) is the leading cause of deafness in the
developed world affecting 80% of preschool children and left undetected,
can lead to learning and developmental problems. It is characterised by the
presence of a middle ear effusion for 3 months or more with a general
absence of gross signs of infection. It is diagnosed in 180,000 children/year
and costs the NHS £18.5million/year to manage surgically and is currently
the only effective treatment to restore hearing. Elucidating the role of
bacteria in the pathogenesis of OME is therefore imperative to allow an
alternative treatment for OME. Using microbiology and confocal laser
scanning microscopy we identiﬁed the bacteria found within the effusions
and demonstrated a wide array of bacteria is often clustered together and
enveloped within mucus. In order to assess the ability of bacteria to form
a bioﬁlm, a novel bacterial adhesion assay demonstrated the ability of
bacteria to adhere to mucosal cells. Studies on the implications of this for
the pathogenesis of OME are continuing. Elucidation of a mechanism that
is employed by bacteria in the progression of this disease would allow
more targeted therapies to be developed and to eventually obviate the
need for surgery.PROSPECTIVE AUDIT ON THE OUTPATIENT MANAGEMENT OF
PERITONSILLAR ABSCESS
George Garas, Sonna Ifeacho, Asit Arora, Neil Tolley. St. Mary\'s Hospital,
Praed Street, London
Introduction: In the UKmost patients with peritonsillar abscess (PTA) are
managed as inpatients. This contradicts routine practice in other devel-
oped countries. There appears to be no consensus over the setting inwhich
PTA patients should be managed (inpatient vs. outpatient) leading to
numerous avoidable acute hospital admissions.
Method: Completed audit cycle over 18 months. First cycle (2008):
retrospective study of management of all PTA patients presenting in A&E
over one year. Intervention: introduction of treatment protocol and formal
lectures to educate A&E doctors. Second cycle (2009): prospective evalu-
ation of management of PTA patients in A&E and assessment of patient
satisfaction with outpatient management by telephone survey.
Results: Signiﬁcant drop in hospital admissions from 69% to 21%. Signif-
icant increase in the proportion of patients satisﬁed with the treatment
they received from 23% to 68%. No adverse outcomes from implementation
of routine outpatient management.
Conclusion: Managing patients with PTA on an outpatient basis is feasible
and safe. It leads to signiﬁcant improvement in all aspects of patient care
and increases patient satisfaction. Finally, it reduces the ﬁnancial impact to
the trust by decreasing the number of hospital admissions at a time where
resources and bed availability in the NHS are limited.
